Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Plasma levels and potential roles of catestatin in patients with coronary heart disease.

Liu L, Ding W, Zhao F, Shi L, Pang Y, Tang C.

Scand Cardiovasc J. 2013 Aug;47(4):217-24. doi: 10.3109/14017431.2013.794951. Epub 2013 May 20.

PMID:
23688154
2.

[Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction].

Ji L, Pei ZQ, Ma DF, Zhang J, Su JS, Gao XD, Xue WZ, Chen XP, Wang WS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):914-9. Chinese.

PMID:
23363671
3.

Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction.

Pei Z, Ma D, Ji L, Zhang J, Su J, Xue W, Chen X, Wang W.

Peptides. 2014 May;55:131-5. doi: 10.1016/j.peptides.2014.02.016. Epub 2014 Mar 11.

PMID:
24631953
4.

Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.

Meng L, Ye XJ, Ding WH, Yang Y, Di BB, Liu L, Huo Y.

J Cardiovasc Med (Hagerstown). 2011 Sep;12(9):643-7. doi: 10.2459/JCM.0b013e328346c142.

PMID:
21508845
5.

Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling.

Meng L, Wang J, Ding WH, Han P, Yang Y, Qi LT, Zhang BW.

Postgrad Med J. 2013 Apr;89(1050):193-6. doi: 10.1136/postgradmedj-2012-131060. Epub 2012 Dec 8.

PMID:
23223776
6.

Plasma levels and diagnostic value of catestatin in patients with heart failure.

Liu L, Ding W, Li R, Ye X, Zhao J, Jiang J, Meng L, Wang J, Chu S, Han X, Peng F.

Peptides. 2013 Aug;46:20-5. doi: 10.1016/j.peptides.2013.05.003. Epub 2013 May 20.

PMID:
23702300
7.

Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction.

Kaya MG, Yalcin R, Okyay K, Poyraz F, Bayraktar N, Pasaoglu H, Boyaci B, Cengel A.

Tex Heart Inst J. 2012;39(4):500-6.

8.

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.

Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2902-8. doi: 10.1161/ATVBAHA.113.302479. Epub 2013 Oct 3.

9.

Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.

Wang X, Xu S, Liang Y, Zhu D, Mi L, Wang G, Gao W.

Biomarkers. 2011 Jun;16(4):372-7. doi: 10.3109/1354750X.2011.578260. Epub 2011 May 5.

PMID:
21545240
10.

The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients.

Peng F, Chu S, Ding W, Liu L, Zhao J, Cui X, Li R, Wang J.

Peptides. 2016 Dec;86:112-117. doi: 10.1016/j.peptides.2016.10.007. Epub 2016 Oct 19.

PMID:
27771336
11.

Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.

Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM.

Cardiovasc J S Afr. 2006 Mar-Apr;17(2):60-6.

13.

The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.

Chan CY, Li R, Chan JY, Zhang Q, Chan CP, Dong M, Yan BP, Lam YY, Yu CM.

Clin Cardiol. 2011 Aug;34(8):507-12. doi: 10.1002/clc.20915. Epub 2011 Jun 29.

14.

Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.

Cavusoglu E, Marmur JD, Hojjati MR, Chopra V, Butala M, Subnani R, Huda MS, Yanamadala S, Ruwende C, Eng C, Pinsky DJ.

Am J Med. 2011 Aug;124(8):724-30. doi: 10.1016/j.amjmed.2011.02.040.

PMID:
21787901
15.

Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.

Eldrup N, Kragelund C, Steffensen R, Nordestgaard BG.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):677-83. doi: 10.1016/j.numecd.2010.11.003. Epub 2010 Dec 30.

PMID:
21194909
16.

Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.

Huang SS, Huang PH, Chen YH, Sung SH, Chiang KH, Chen JW, Lin SJ.

Coron Artery Dis. 2008 Dec;19(8):597-602. doi: 10.1097/MCA.0b013e3283155579.

PMID:
18971786
17.
18.

Dose-dependent prognostic effect of carvedilol in patients with chronic heart failure--special reference to transcardiac [corrected] gradient of norepinephrine.

Nishiyama K, Tsutamoto T, Yamaji M, Kawahara C, Yamamoto T, Fujii M, Horie M.

Circ J. 2009 Dec;73(12):2270-5. Epub 2009 Oct 17. Erratum in: Circ J. 2010 Feb;74(2):385.

19.

The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up.

Gul M, Uyarel H, Ergelen M, Karacimen D, Ugur M, Turer A, Bozbay M, Ayhan E, Akgul O, Uslu N.

Coron Artery Dis. 2012 Aug;23(5):330-6. doi: 10.1097/MCA.0b013e3283564986.

PMID:
22735091
20.

Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction.

Zhu D, Xie H, Wang X, Liang Y, Yu H, Gao W.

PLoS One. 2015 Apr 7;10(4):e0122993. doi: 10.1371/journal.pone.0122993. eCollection 2015.

Supplemental Content

Support Center